Sanofi has announced that it will lower the list price of its insulin drug, Lantus, by 78 percent and will set a $35 cap on out-of-pocket costs for all patients.
The price change and cap will go into effect starting January 1, 2024. They follow a series of moves made last year to lower the price of diabetes medicine, including the launch of an unbranded version of Lantus and a $35 cap for uninsured patients.
Yet, Olivier Bogillot, head of U.S. general medicines at Sanofi, said "the health system was unable to take advantage of it due to its inherent structural challenges."
“Sanofi believes that no one should struggle to pay for their insulin and we are proud of our continued actions to improve access and affordability for millions of patients for many years," he said. "Our decision to cut the list price of our lead insulin needs to be coupled with broader change to the overall system to actually drive savings for patients at the pharmacy counter.”
Sanofi will also cut the price of short-acting Apidra by 70 percent.
Fed Chair Jerome Powell said higher rates are here to stay for now.
Jenna Helwig, food director at 'Real Simple,' joined Cheddar News to provide tips on how to save on purchasing kitchen gadgets ahead of the holiday season and which essentials are needed when cooking.
You may soon be able to charge your car while driving. Cheddar News explains.
The holiday season is underway and it's a good time to put your Christmas tree up if you haven't already. But making your home festive can be costly. Cameron Forbes, founder of Forbes Functions, joined Cheddar News to provide tips for decorating on a dime.
Google is moving forward with its previously-announced plan to delete inactive accounts and all associated data.
Federal regulators are investigating Chevrolet Volt hybrid cars after some drivers reported issues including sudden power loss and failure to restart.
Fed Chair Jerome Powell weighed in on interest rates, some of Tesla's cybertrucks have been delivered, Apple and Paramount have reportedly discussed bundling their streaming services together and Panera Bread has reportedly filed to go public.
Accounting firm PWC is facing a $7 million fine from U.S. regulators.
Build-A-Bear Workshop has been one of the most recognizable and beloved toy brands in the world since opening in 1997. Sharon Price John, CEO of Build-A-Bear Workshop, spoke with Cheddar News about its plans for the holiday season this year as well as the company's first animated feature film.
Pfizer will stop the development of its twice-daily weight loss pill due to adverse side effects.
